Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and Quality

Veeva Systems (NYSE: VEEV) will showcase AI offerings at its R&D and Quality Summit on October 20-21 in Boston.

Rhea-AI Summary

Veeva Systems (NYSE: VEEV) will showcase AI offerings at its R&D and Quality Summit on October 20-21 in Boston. The event will bring together life sciences professionals, including participants from Eli Lilly and Company, Pfizer, Sanofi, UCB, Duke University, and the University of Pennsylvania.

More than 100 sessions will cover AI and automation, connected clinical trials, and quality and manufacturing. Highlights include Veeva Falcon, Vault AI, and new capabilities in Veeva Development Cloud and Veeva Quality Cloud. The summit is open exclusively to life sciences professionals.

Key Figures

Sessions: More than 100 sessions Attendees: More than 2,500 attendees

Sessions

More than 100 sessions

Veeva R&D and Quality Summit

Attendees

More than 2,500 attendees

Veeva R&D and Quality Summit

Key Terms

cros, ehr, edc, lims, +1 more

5 terms

cros technical

"emerging biotechs, CROs, and sites"

Contract research organizations (CROs) are independent firms hired by drug and medical-device companies to run research tasks such as clinical trials, patient recruitment, lab testing, data management, and regulatory filings. For investors they matter because CROs act like contractors turning a sponsor’s plans into finished work—so their capacity, timelines, costs and quality directly affect how quickly and cheaply a drug or device can move toward approval and revenue.

ehr technical

"direct data from EHR to EDC"

EHR stands for electronic health record, a digital version of a patient’s complete medical file that replaces paper charts and collects diagnoses, medications, test results and treatment history in one place. For investors, EHR systems matter because they drive recurring revenue for software and services, affect healthcare providers’ costs and efficiency, and create data assets and integration opportunities that can influence a company’s growth and regulatory risk.

edc technical

"direct data from EHR to EDC"

An electronic data capture (EDC) system is software used to collect, store and manage clinical trial information digitally instead of on paper. Think of it as a secure online form and filing cabinet that organizes patient visits, test results and compliance records; faster, cleaner data helps sponsors spot problems sooner, shorten development timelines and reduce regulatory risk. Investors track EDC quality because it can speed trials, cut costs and affect the credibility of trial results.

lims technical

"piloting cloud LIMS to speed global delivery"

A LIMS is software that manages laboratory samples, test results, workflows and quality records, acting like a digital filing cabinet and task manager for labs. Investors care because it helps labs run faster, reduce errors, and meet regulatory rules—improvements that can lower costs, speed product development or approvals, and make a company’s scientific results more reliable, much like a well-organized operations hub improves a factory’s output.

gxp regulatory

"integrated learning system for GxP compliance"

gxp (often written GxP) is an umbrella term for a family of quality guidelines and regulatory standards—such as Good Manufacturing Practice (GMP), Good Clinical Practice (GCP) and Good Laboratory Practice (GLP)—used in regulated industries to ensure products, processes and data are consistently produced, controlled and documented to meet safety, quality and integrity requirements. It works by prescribing principles and operational controls (written procedures, record-keeping, personnel training, equipment qualification, validation, traceability and regular internal and external audits or inspections) rather than a single rule; specific obligations depend on the particular GxP standard and the regulator that enforces it. GxP compliance ensures processes and records meet regulatory expectations but is not a standalone proof of product effectiveness or commercial success.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Eli Lilly and Company, Pfizer, Sanofi, UCB, and more share learnings speeding drug development, connecting trials, and modernizing quality and manufacturing

PLEASANTON, Calif., Oct. 8, 2026 /PRNewswire/ -- At Veeva R&D and Quality Summit on October 20-21 in Boston, Veeva Systems (NYSE: VEEV) will bring together leading biopharmas, emerging biotechs, CROs, and sites — including Duke University, Eli Lilly and Company, Pfizer, Sanofi, Tolmar, UCB, and the University of Pennsylvania — to explain how they are driving new ways of working across drug development and quality.

Veeva will share its vision to power agentic biopharma for the industry with deep AI for clinical, regulatory, safety, and quality operations. New highlighted innovations include Veeva Falcon agentic labor, Vault AI agentic platform and agents, and new capabilities in Veeva Development Cloud and Veeva Quality Cloud applications.

More than 100 sessions will feature roadmaps, product highlights, and customer success, including:

Driving AI and automation for productivity and speed

• Eli Lilly and Company rolling out AI to improve productivity, accelerate submissions, and prepare the workforce of the future
• UCB unifying safety for automated case processing, full signal to source traceability, and a data foundation for AI

Delivering connected trials for patients, sites, sponsors, and CROs

• Duke University and another leading cancer center discussing scalable site-centric eSource strategies with direct data from EHR to EDC
• Sanofi building a connected, patient-first clinical ecosystem for a better trial experience

Modernizing quality and manufacturing to remove silos and create efficiencies

• Pfizer piloting cloud LIMS to speed global delivery of medicines and set the path for AI
• Tolmar creating an integrated learning system for GxP compliance and professional development

More than 2,500 attendees come together to connect with industry peers at the Veeva R&D and Quality Summit. The event is open exclusively to life sciences professionals, who can register and stay up to date on the agenda at veeva.com/Summit.

About Veeva Systems
Veeva delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

Veeva Forward-Looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the fiscal year ended July 31, 2026, which you can find here (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov.

Contact:

Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/veeva-summit-to-showcase-ai-innovations-and-the-leaders-transforming-rd-and-quality-302902012.html

SOURCE Veeva Systems